BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7613138)

  • 1. The interleukin-5/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils.
    Alam R; Pazdrak K; Stafford S; Forsythe P
    Int Arch Allergy Immunol; 1995; 107(1-3):226-7. PubMed ID: 7613138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway.
    Pazdrak K; Schreiber D; Forsythe P; Justement L; Alam R
    J Exp Med; 1995 May; 181(5):1827-34. PubMed ID: 7722458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor.
    Pazdrak K; Justement L; Alam R
    J Immunol; 1995 Nov; 155(9):4454-8. PubMed ID: 7594607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils.
    Hiraguri M; Miike S; Sano H; Kurasawa K; Saito Y; Iwamoto I
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S45-51. PubMed ID: 9440544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.
    Xia K; Mukhopadhyay NK; Inhorn RC; Barber DL; Rose PE; Lee RS; Narsimhan RP; D'Andrea AD; Griffin JD; Roberts TM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11681-6. PubMed ID: 8876196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.
    Stancato LF; Sakatsume M; David M; Dent P; Dong F; Petricoin EF; Krolewski JJ; Silvennoinen O; Saharinen P; Pierce J; Marshall CJ; Sturgill T; Finbloom DS; Larner AC
    Mol Cell Biol; 1997 Jul; 17(7):3833-40. PubMed ID: 9199317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils.
    Pazdrak K; Stafford S; Alam R
    J Immunol; 1995 Jul; 155(1):397-402. PubMed ID: 7602114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils.
    Bates ME; Bertics PJ; Busse WW
    J Immunol; 1996 Jan; 156(2):711-8. PubMed ID: 8543824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of IL-5 signal transduction.
    Adachi T; Alam R
    Am J Physiol; 1998 Sep; 275(3):C623-33. PubMed ID: 9730944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human IL-5 receptor.
    Ogata N; Kikuchi Y; Kouro T; Tomonaga M; Takatsu K
    Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():24-7. PubMed ID: 9363920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of JAK2, but not PI 3-kinase/Akt and MAP kinase pathways, in anti-apoptotic signals of GM-CSF in human eosinophils.
    Miike S; Nakao A; Hiraguri M; Kurasawa K; Saito Y; Iwamoto I
    J Leukoc Biol; 1999 May; 65(5):700-6. PubMed ID: 10331501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone.
    Winston LA; Hunter T
    J Biol Chem; 1995 Dec; 270(52):30837-40. PubMed ID: 8537333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation.
    Pazdrak K; Olszewska-Pazdrak B; Stafford S; Garofalo RP; Alam R
    J Exp Med; 1998 Aug; 188(3):421-9. PubMed ID: 9687520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation.
    Stafford S; Lowell C; Sur S; Alam R
    J Immunol; 2002 Feb; 168(4):1978-83. PubMed ID: 11823534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C; Ng J; Babbage JW; Cantrell DA
    EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras.
    Jaiswal RK; Moodie SA; Wolfman A; Landreth GE
    Mol Cell Biol; 1994 Oct; 14(10):6944-53. PubMed ID: 7935411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
    Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.